Compare ALIT & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALIT | YDES |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 568.2M | 543.0M |
| IPO Year | 2020 | N/A |
| Metric | ALIT | YDES |
|---|---|---|
| Price | $16.98 | $2.17 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.75 | N/A |
| AVG Volume (30 Days) | ★ 714.3K | 311.7K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 21.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,262,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $1.70 |
| 52 Week High | $23.68 | $25.00 |
| Indicator | ALIT | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 56.14 | 47.05 |
| Support Level | $1.12 | $1.93 |
| Resistance Level | $23.68 | $3.05 |
| Average True Range (ATR) | 1.71 | 0.33 |
| MACD | -0.90 | 0.06 |
| Stochastic Oscillator | 2.91 | 44.44 |
Alight Inc is a technology-enabled services company delivering human capital management solutions to many complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth, and leave benefits) solutions, which currently operate under one reportable segment, Employer Solutions. The Employer Solutions segment is driven by the Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial well-being, leave of absence management, and retiree healthcare. Geographically, the company generates the majority of its revenue from the United States.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.